ONWARD Medical H1 FY26 operating loss widens to EUR 23.3 million; revenue climbs 240% to EUR 4.2 million

Reuters2026/09/09 05:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ONWARD Medical posted H1 2026 revenue of EUR 4.2 million, up from EUR 1.2 million a year earlier.
ARC-EX revenue more than doubled to EUR 3.4 million, driven by 159 systems sold or supplied via paid evaluation, up 430% year over year.
Operating loss widened to EUR 23.3 million; net loss deepened to EUR 24.7 million.
Cash rose to EUR 81.5 million after raising EUR 40.6 million in equity; it also secured up to EUR 50 million from BlackRock.
Empower BP enrolled 22 participants with 14 active sites; CEO Dave Marver cited strong ARC-EX traction and pipeline progress.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ONWARD Medical NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609090130OMX_____CNEWS_EN_GNW9823262_en) on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

ONWARD Medical H1 FY26 operating loss widens to EUR 23.3 million; revenue climbs 240% to EUR 4.2 million

You may also like

Crypto prices